Pharmaceutical Discount Agreements Pursuant To Section 130A Para 8 Sgb V Within The Framework Of Open House Procedures

Deadline: 06 May 2026

Germany

Ref. No.: 6283816

EMD:Ref Document

Bid Value: Ref Document

47 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6261602

EMD:Ref Document

Bid Value: Ref Document

286 Days Left

Open House Contracts For Multiple Active Ingredients Active Ingredient Combinations

Deadline: 01 Jun 2026

Germany

Ref. No.: 6230074

EMD:Ref Document

Bid Value: Ref Document

73 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6229837

EMD:Ref Document

Bid Value: Ref Document

286 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Oralair Atc Code According To Who V01Aa02

Deadline: 31 Jul 2026

Germany

Ref. No.: 6175344

EMD:Ref Document

Bid Value: Ref Document

133 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Lipegfilgrastim Atc Code According To Who L03Aa14

Deadline: 30 Apr 2026

Germany

Ref. No.: 6174040

EMD:Ref Document

Bid Value: Ref Document

41 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Orylmyte Atc Code According To Who V01Aa03

Deadline: 31 Jul 2026

Germany

Ref. No.: 6173952

EMD:Ref Document

Bid Value: Ref Document

133 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Itulazax Atc Code According To Who V01Aa05

Deadline: 31 Jul 2026

Germany

Ref. No.: 6171828

EMD:Ref Document

Bid Value: Ref Document

133 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Fentanyl In The Dosage Form Of Sublingual Tablets Atc Code According To Wh

Deadline: 30 Jun 2026

Germany

Ref. No.: 6165516

EMD:Ref Document

Bid Value: Ref Document

102 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6111501

EMD:Ref Document

Bid Value: Ref Document

286 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ustekinumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 6108284

EMD:Ref Document

Bid Value: Ref Document

143 Days Left

Devcom Army Research Laboratory Broad Agency Announcement For Foundational Research

Deadline: 20 Nov 2027

United States

Ref. No.: 6108095

EMD:Ref Document

Bid Value: Ref Document

610 Days Left

Open Framework Agreement On Drug Discounts In Accordance With Section 130A Paragraph 8 Of The Social Code Book V With The Option To Join At Any Time So Called Approval Model 2024 06

Deadline: 05 Jun 2026

Germany

Ref. No.: 6107624

EMD:Ref Document

Bid Value: Ref Document

77 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6103773

EMD:Ref Document

Bid Value: Ref Document

286 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ustekinumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 6065652

EMD:Ref Document

Bid Value: Ref Document

143 Days Left

Discover Tenders by Laboratory Hygienic Or Pharmaceutical Glassware Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Laboratory Hygienic Or Pharmaceutical Glassware Sector

Filter Your Search

FREE Trial plan for all new users!